Trial intelligence / Profile preview

NSAIDs and Bone Metabolism After Plyometric Exercise

NCT05512013Phase 1Completed

Sponsor
U.S. Army Research Institute of Environmental Medicine
Start
Feb 2022
Primary completion
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of ibuprofen, celecoxib oral solution and flurbiprofen in Bone resorption, stress fracture and bone fracture (Fx), sponsored by U.S. Army Research Institute of Environmental Medicine. Started Feb 2022; status: completed.

02

Drugs

ibuprofencelecoxib oral solutionflurbiprofen
03

Conditions

Bone resorptionstress fracturebone fracture (Fx)

Beyond the preview

Go deeper on NCT05512013.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05512013.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call